ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Lobe Sciences Ltd

Lobe Sciences Ltd (LOBE)

0,10
0,00
( 0,00% )
Aktualisiert: 15:30:03

Lobe Sciences Ltd (LOBE) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,10
( - )
Gebot
0,095
Fragen
0,12
Volumen
-
0,00 Tagesbereich 0,00
0,03 52-Wochen-Bereich 0,18
Marktkapitalisierung
Handelsende
0,10
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
$ 98.880
Ausgegebene Aktien
284.102.518
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-3,25
Gewinn pro Aktie (EPS)
-0,03
Erlöse (LTM)
-
Nettogewinn (LTM)
-5,62M

Über Lobe Sciences Ltd

Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly kno... Lobe Sciences Ltd., a biopharmaceutical company, engages in the research and development of lipid technology to develop innovative treatments for orphan and rare diseases. It offers Altemia® MF, a medical food designed to manage deficiencies in sickle cel disease. Lobe Sciences Ltd. was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. The company was founded in 2018 and is headquartered in Vancouver, Canada. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Vancouver, Canada
Gegründet
2026
Lobe Sciences Ltd is listed in the Healthcare sector of the Canadian Securities Exchange with ticker LOBE. The last closing price for Lobe Sciences was $0,10. Over the last year, Lobe Sciences shares have traded in a share price range of $ 0,03 to $ 0,18.

Lobe Sciences currently has 284.102.518 shares in issue. The market capitalisation of Lobe Sciences is $28,41 million. Lobe Sciences has a price to earnings ratio (PE ratio) of -3.25.

LOBE Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.0111.11111111110.090.10.09377420.09026271CS
4-0.015-13.04347826090.1150.1350.075349970.09030891CS
120.0342.85714285710.070.180.07887860.1139737CS
260.051000.050.180.04945440.08779711CS
520.065185.7142857140.0350.180.03773040.07426662CS
1560.07233.3333333330.030.180.01487880.04983646CS
260-0.005-4.76190476190.1050.290.01943520.04888009CS

LOBE - Frequently Asked Questions (FAQ)

What is the current Lobe Sciences Ltd share price?
The current share price of Lobe Sciences Ltd is $ 0,10
How many Lobe Sciences Ltd shares are in issue?
Lobe Sciences Ltd has 284.102.518 shares in issue
What is the market cap of Lobe Sciences Ltd?
The market capitalisation of Lobe Sciences Ltd is CAD 28,41M
What is the 1 year trading range for Lobe Sciences Ltd share price?
Lobe Sciences Ltd has traded in the range of $ 0,03 to $ 0,18 during the past year
What is the PE ratio of Lobe Sciences Ltd?
The price to earnings ratio of Lobe Sciences Ltd is -3,25
What is the registered address of Lobe Sciences Ltd?
The registered address for Lobe Sciences Ltd is 1771 Robson Street, Vancouver, British Columbia, V6G 3B7
What is the Lobe Sciences Ltd website address?
The website address for Lobe Sciences Ltd is www.lobesciences.com
Which industry sector does Lobe Sciences Ltd operate in?
Lobe Sciences Ltd operates in the Biotechnology & Life Sciences sector

LOBE Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen